SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
PBX3 | hg19_v2_chr9_+_128510454_128510478 | 0.33 | 1.6e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 16.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
4.0 | 16.1 | GO:0070893 | transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
0.6 | 13.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.3 | 12.3 | GO:0006783 | heme biosynthetic process(GO:0006783) |
2.4 | 12.2 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
2.6 | 10.5 | GO:0072086 | specification of loop of Henle identity(GO:0072086) pattern specification involved in metanephros development(GO:0072268) |
0.4 | 8.6 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
1.1 | 8.0 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 8.0 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 7.8 | GO:0000209 | protein polyubiquitination(GO:0000209) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 16.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 15.6 | GO:0016605 | PML body(GO:0016605) |
0.0 | 13.2 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 10.4 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 10.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.6 | 9.6 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 9.1 | GO:0044309 | neuron spine(GO:0044309) |
0.0 | 7.6 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 6.2 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 5.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 85.5 | GO:0003677 | DNA binding(GO:0003677) |
0.1 | 39.0 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.5 | 12.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 11.9 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 10.0 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.1 | 9.8 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.4 | 9.7 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.2 | 9.7 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 9.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 9.0 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 16.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.6 | 16.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 8.9 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 8.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 8.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 7.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 6.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 6.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 4.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 4.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 34.2 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.2 | 12.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 11.1 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.2 | 8.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 8.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 7.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 6.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 5.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 5.8 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 5.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |